APA (7th ed.) Citation

Roche, A., Chennell, P., Chiambaretta, F., Serre-Sapin, A. F., Wasiak, M., Bouattour, Y., . . . Sautou, V. (2025). Development of an ophthalmic solution combining allogenic plasma with protective excipients for enhanced therapeutic role in the management of ocular surface diseases. European Journal of Pharmaceutics & Biopharmaceutics, 214, N.PAG. https://doi.org/10.1016/j.ejpb.2025.114813

Chicago Style (17th ed.) Citation

Roche, Agnès, et al. "Development of an Ophthalmic Solution Combining Allogenic Plasma with Protective Excipients for Enhanced Therapeutic Role in the Management of Ocular Surface Diseases." European Journal of Pharmaceutics & Biopharmaceutics 214 (2025): N.PAG. https://doi.org/10.1016/j.ejpb.2025.114813.

MLA (9th ed.) Citation

Roche, Agnès, et al. "Development of an Ophthalmic Solution Combining Allogenic Plasma with Protective Excipients for Enhanced Therapeutic Role in the Management of Ocular Surface Diseases." European Journal of Pharmaceutics & Biopharmaceutics, vol. 214, 2025, p. N.PAG, https://doi.org/10.1016/j.ejpb.2025.114813.